(Reuters) -Eli Lilly hit $1 trillion in market value on Friday, making it the first drugmaker to enter the exclusive club dominated by tech giants and underscoring its rise as a weight-loss powerhouse.
Here are some reactions to Lilly joining the trillion dollar club:
EVAN SEIGERMAN, ANALYST AT BMO CAPITAL MARKETS
"The current valuation points to investor confidence in the longer-term durability of the company's metabolic health franchise. It also suggests that investors prefer Lilly over Novo in the obesity arms race. Taking a step back, we're also seeing money rotate into the sector as investors may be worried about an AI bubble."
HANK SMITH, DIRECTOR & HEAD OF INVESTMENT STRATEGY AT LILLY SHAREHOLDER HAVERFORD TRUST
"Investors have historically liked secure earnings growth and (Eli Lilly) is the only large cap pharma that has that kind of earnings profile."
(Reporting by Siddhi Mahatole and Shashwat Chauhan in Bengaluru; Editing by Leroy Leo)
LATEST POSTS
- 1
What's The Friendliest City In The United Kingdom? - 2Meet ‘NASA Mike,’ who’s done 105,000 handstands around the world
- 3Find the Standards of Viable Refereeing: Settling Debates with Strategy
- 4Good ways to respond if your kid brings home less-than-ideal grades
- 5Instructions to Construct an Organization While Chasing after a Web-based Degree
- Vote In favor of Your Favored Shades
- A whale stranded at a Baltic Sea resort has swum off a sandbank. But it isn't safe yet
- British-Egyptian dissident apologises for tweets as Tories push for UK deportation
- We tasted one of the 10,000 Hershey's Dubai chocolate bars being resold on eBay. Is it worth the hype?
- A Colombian city swaps iconic horse buggies for electric carriages amid animal welfare concerns
- Step by step instructions to Protect Your Senior Condo for Ideal Wellbeing and Solace
- The Red Sea strategy: What does Israel stand to gain from recognizing Somaliland?
- These are the Fastest Italian Sports Cars
- Vote in favor of your Favored kind of footwear
